Report
Xylazine (CCENDU Drug Alert)
Publication date:
2022
Publisher:
Canadian Centre on Substance Use and Addiction
Summarizes the increased risk of accidental overdose due to xylazine in Canada’s unregulated drug supply. Xylazine is a non-opioid pain reliever developed as a sedative and muscle relaxant for animals. It is being found as an adulterant in other drugs. In combination with other sedatives like fentanyl, benzodiazepines or alcohol, xylazine can increase the risk of overdose and death.